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Abstract
Previous studies on the association between alcohol intake and the development of the metabolic syndrome (MetS) have yielded
inconsistent results. Besides, few studies have analysed the effects of red wine (RW) consumption on the prevalence of the MetS and
its components. As moderate RW drinkers have a better lipid profile and lower incidence rates of diabetes, hypertension and abdominal
obesity, all components of the MetS, it was hypothesised that moderate RW consumption could be associated with a lower prevalence of
the MetS. In the present cross-sectional study of 5801 elderly participants at a high cardiovascular risk included in the PREDIMED (Preven-
cio´n con Dieta Mediterra´nea) study, 3897 fulfilled the criteria of the MetS at baseline. RW intake was recorded using a validated 137-item
FFQ. Multiple logistic regression analysis was carried out to estimate the association between RW intake and the prevalence of the MetS.
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Compared with non-drinkers, moderate RW drinkers ($1 drink/d) were found to have a reduced risk of prevalent MetS (OR 0·56, 95 % CI
0·45, 0·68; P,0·001), a lower risk of having an abnormal waist circumference (OR 0·59, 95 % CI 0·46, 0·77; P,0·001), low HDL-cholesterol
concentrations (OR 0·42, 95 % CI 0·32, 0·53; P,0·001), high blood pressure (OR 0·28, 95 % CI 0·17, 0·45; P,0·001) and high fasting plasma
glucose concentrations (OR 0·67, 95 % CI 0·54, 0·82; P,0·001) after adjusting for several confounders. This association was found to be
stronger in female participants, in participants aged ,70 years and in participants who were former or current smokers. No significant
association was found between RW intake ($1 drink/d) and TAG concentrations. In conclusion, moderate RW consumption is associated
with a lower prevalence of the MetS in an elderly Mediterranean population at a high cardiovascular risk.
Key words: Red wine: Alcohol: Metabolic syndrome
The metabolic syndrome (MetS), a cluster of metabolic
abnormalities that includes abdominal obesity, hypertriacyl-
glycerolaemia, low HDL-cholesterol (HDL-c) concentrations,
hypertension and hyperglycaemia, has become a major public
health concern(1). It results from the interaction of multiple
factors, including genetic and environmental factors, with
the dietary habits playing a crucial role in its development(2).
Previous studies have found both positive and negative
effects of alcohol intake on the risk of MetS(3). However, in a
meta-analysis of observational studies, Alkerwi et al.(4) showed
that a favourable metabolic effect appeared to be restricted
to moderate alcohol intake, namely ,20 g/d in women and
,40 g/d in men. While some authors have found no differences
in the incidence rates of the MetS among consumers of various
alcoholic drinks, others have reported lower incidence rates
among wine drinkers(3,5). However, using a longitudinal design
in the SUN (Seguimiento Universidad de Navarra) study, Barrio-
Lopez et al.(5) found that consumers of at least seven alcoholic
drinks per week had increased odds of developing the MetS,
but they did not find any significant association between wine
or liquor consumption and the MetS. Besides containing alco-
hol, red wine (RW) is rich in polyphenols, which may benefi-
cially influence carbohydrate metabolism(6) and blood pressure
(BP)(7,8). Furthermore, different human intervention studies
have shown that other foods rich in polyphenols increase
HDL-c concentrations(9–11); however, the few human studies
that have been conducted on the effects of polyphenol-rich
foods on abdominal adiposity have yielded conflicting results,
with studies showing positive effects(12,13) or no effect(14).
The purpose of the present study was to investigate the
association between RW consumption and the prevalence
of the MetS and its components in an elderly Mediterranean
population at a high cardiovascular risk.
Subjects and methods
Subjects
A cross-sectional study was conducted using baseline data
obtained from the cohort of the PREDIMED study. A detailed
description of the study has been published previously(15).
This study was conducted according to the guidelines laid
down in the Declaration of Helsinki, and all procedures
involving human subjects/patients were approved by the
Institutional Review Boards of the participating centres (Clini-
cal Trial Registration: ISRCTN of London, England: 35739639).
Written informed consent was obtained from all participants.
Of the 5969 participants from all the PREDIMED centres with
complete biochemical analysis data, 140 who did not complete
the FFQ at baseline and twenty-eight with extreme total
energy intakes were excluded from the present study(16). Thus,
data from 5801 participants were available for the analyses.
Assessment of population characteristics
and dietary habits
Dietary habits at baseline were evaluated using a validated
137-item FFQ(17). Daily food and nutrient intakes were
estimated from the FFQ by multiplying the frequency of con-
sumption by the average portion size. A validated 14-point
questionnaire was also used(18), but excluding alcohol intake,
to assess the adherence to the traditional Mediterranean diet
(MedDiet). The participants also filled out a general question-
naire on lifestyle habits, medication use and concurrent
diseases and a validated Spanish version of the Minnesota
Leisure Time Physical Activity Questionnaire(19).
Anthropometric measurements and blood analyses
Body weight and height were measured with minimum
clothing andno shoes, using calibrated scales andwall-mounted
stadiometers, respectively. The BMI was calculated as weight in
kgdividedby the square of height inm.Waist circumferencewas
measured mid-way between the lowest rib and iliac crest using
an anthropometric tape. The waist:height ratio was assessed
by dividing the waist circumference by height, as a practical
index for assessing central fat distribution. BP was measured
in a sitting position, using a semi-automatic sphygmomano-
meter (Omron HEM-705CP), in triplicate with a 5 min interval
between each measurement, and the mean of these values
was recorded according to the procedures recommended by
the European Hypertension Society(20). Plasma glucose and
lipid profiles were measured using an automatic analyser in a
routine laboratory test. For patients with TAG concentrations
,400 mg/dl, LDL-cholesterol concentrations were estimated
using the Friedewald formula(21).
Categories of red wine intake
The FFQ included questions concerning the intake of wines
(RW, rose´ wine, white wine and sparkling wine), beer, liquors
and spirits. Standard drinks (hereafter referred to as ‘drinks’),
10 g of pure alcohol, were used to categorise alcohol intake.
The drinks included 100 ml of wine, 250 ml of beer, 65 ml of
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liquors and 32 ml of spirits. The participants were categorised
into three groups based on their RW intake: non-drinkers;
0·1–1 drink/d; .1 drink/d.
Definition of the metabolic syndrome
The MetS was defined in accordance with the updated
harmonised International Diabetes Federation (IDF) and the
American Heart Association/National Heart, Lung, and Blood
Institute (AHA/NHLBI) criteria(22). The participants were iden-
tified as having the MetS, as defined in the American Journal
of Clinical Nutrition (AJCN/2014/086991 version 1), when they
had at least three of the following components: (1) elevated
waist circumference for European individuals (.102 cm in
men; .88 in women); (2) elevated TAG concentrations
(.150 mg/dl (1·7 mmol/l)) or drug treatment for elevated TAG
concentrations; (3) low HDL-c concentrations (#40 mg/dl
(1·0 mmol/l) in men; #50 mg/dl (1·3 mmol/l) in women) or
drug treatment for low HDL-c concentrations; (4) elevated
BP (systolic $130 and/or diastolic $85 mmHg) or antihyper-
tensive drug treatment; (5) elevated fasting glucose concentra-
tions (.100 mg/dl (5·5 mmol/l)) or drug treatment for diabetes.
Statistical analyses
The means of continuous variables among the different
RW intake groups were compared using one-way ANOVA
with the Bonferroni post hoc test. If the variable did not
follow a normal distribution (skewness or kurtosis .22 or
,2), the corresponding non-parametrical Mann–Whitney
and Kruskal–Wallis tests were performed. The x 2 test or the
Fisher exact test was used for analysing categorical variables.
Pearson’s correlation coefficients were calculated to test
the linear association between the intake of RW and that of
other alcoholic beverages (white and sparkling wines, beer,
liquors and spirits), all as continuous variables.
The OR for the MetS and each of its components in
the different RW intake categories were calculated using
multiple logistic regression analysis, with the outcome as the
dependent variable and the intake groups as independent
variables. Multivariate models were adjusted for sex, age
(continuous), BMI (continuous), smoking status (never,
former and current), physical activity during leisure time
(yes/no), energy intake (continuous), educational level and
adherence to the Mediterranean food pattern excluding wine
intake (continuous). Additional analyses stratified by sex,
age groups (,70 years and $70 years) and smoking status
(never/ever) were carried out and the effect modification of
these variables with alcohol was evaluated using likelihood
ratio tests for the product term introduced in the crude and
fully adjusted models. All statistical analyses were conducted
using IBM SPSS software version 19.0. All t tests were two-
sided and P values ,0·05 were considered significant.
Results
A total of 5801 PREDIMED study participants (2433 men and
3368 women) at a high cardiovascular risk were included in
the present study. The baseline characteristics of the study
participants according to categories of energy-adjusted RW
intake at baseline are summarised in Table 1. More than
50 % of the study population did not consume RW (3037
participants), 36 % consumed ,1 drink/d (2086 participants)
and 12 % consumed .1 drink/d (678 participants). Of these,
only 111 participants consumed $5 drinks/d. Participants
with the highest RW intake were found to more likely be
men, current or former smokers, and more physically active
and have a higher educational level. The dietary pattern of the
participants distributed into RW intake categories is summa-
rised in Table 2. Those who drank more RW (.1 drink/d)
were found to have a higher intake of carbohydrates, protein,
SFA, MUFA and PUFA, total cholesterol and total energy. Less
frequent consumption of fruits, vegetables and dairy products
was observed in the group of moderate/heavy drinkers,
although no significant differences were observed in the
adherence to the traditional MedDiet among the three groups.
The linear association between the intake of RW and that of
other alcoholic beverages was also tested (Table 3). Although
Table 1. Baseline characteristics of participants from the PREDIMED (Prevencio´n con Dieta Mediterra´nea) cohort according to categories of red wine
(RW) intake at baseline (energy-adjusted)
(Number of participants; percentages; mean values and standard deviations)
Non-drinkers 0·1–1 drink/d .1 drink/d
Characteristics n Percentage of the total n Percentage of the total n Percentage of the total P *
No. of participants (5801) 3037 52·4 2086 36·0 678 11·7
Sex, women 2299 75·7 973 46·6 96 14·2 ,0·001
Current smoker 276 9·1 324 15·5 193 28·5 ,0·001
Former smoker 464 15·3 645 30·9 292 43·1 ,0·001
Higher education 328 10·8 395 18·9 160 23·6 ,0·001
Mean SD Mean SD Mean SD P†
RW intake (units/d) 0 0·0 0·51 0·4 2·9 1·2 ,0·001
Age (years) 67·9 6·0 66·3 6·2 65·7 6·1 ,0·001
Energy expenditure in
physical activity (kJ/d)
829·3 871·1 1042·9 1050·0 1398·6 1147·0 ,0·001
* x 2 tests.
† One-way ANOVA tests.
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the correlation coefficients were significant, only weak linear
associations were found among the variables. In general, the
intake of RW was found to be positively correlated with the
intake of beer, liquors and spirits, but not with that of other
types of wines when analysing the entire sample or stratifying
the sample by sex.
Association between red wine consumption and the
prevalence of the metabolic syndrome
Among the 5801 participants included in the analyses, 3897
(67 %) fulfilled the criteria for the MetS. The metabolic risk
parameters according to the RW intake categories are sum-
marised in Table 4. Participants with the highest RW intake
had lower BMI and heart rate, but higher BP. No significant
differences were observed in total cholesterol or HDL-c con-
centrations across the groups. However, when these values
were translated to MetS components taking into account the
medications used to treat triacylglycerolaemia, hypertension
or diabetes, fewer MetS cases were observed among the
highest RW consumers, as well as a lower prevalence of
abnormal waist circumference, high TAG concentrations or
lipid-lowering treatment, low HDL-c concentrations, high BP
or antihypertensive treatment, and high fasting plasma glucose
concentrations or antidiabetic treatment.
The relative risk was calculated using logistic regression
models with non-drinkers as the reference category. Risks cal-
culated using crude models and after adjusting for possible
confounders (sex, age, BMI, smoking status, educational
level, physical activity, total energy intake and diet) differed
significantly (Table 5). Consumption of less than one drink
of RW per d was found to be associated with a significantly
lower risk of the MetS in both the crude and adjusted
models (OR 0·56, 95 % CI 0·45, 0·68; P,0·001). The same
association was found when the fully adjusted OR for the
highest RW intake category was estimated after excluding
Table 2. Dietary pattern of 5801 participants from the PREDIMED (Prevencio´n con Dieta Mediterra´nea) cohort according to
categories of red wine (RW) intake at baseline (energy-adjusted)
(Mean values and standard deviations)
Non-drinkers
(n 3037)
0·1–1 drink/d
(n 2086)
.1 drink/d
(n 678)
Mean SD Mean SD Mean SD P*
Alcoholic beverages (units/d)
RW 0·00 0·00 0·51 0·38 2·92 1·19 ,0·001
White, rose´ and sparkling wines 0·10 0·51 0·08 0·36 0·11 0·47 0·36
Beer 0·09 0·37 0·22 0·56 0·37 0·79 ,0·001
Liquors/spirits 0·005 0·06 0·01 0·08 0·03 0·10 ,0·001
Nutrient intake
Total energy intake ,0·001
kJ/d 8875·5 2174 9660 2185·7 10 880 2118·7
kcal/d 2121·3 519·6 2308·8 522·4 2600·4 506·4
Carbohydrates (g/d) 228·3 72·4 238·7 72·7 251·3 75·2 ,0·001
Protein (g/d) 89·2 21·3 94·3 21·4 95·7 20·3 ,0·001
SFA (g/d) 23·7 8·5 26·1 8·3 26·9 8·2 ,0·001
MUFA (g/d) 46·0 15·0 50·5 14·9 52·9 14·2 ,0·001
PUFA (g/d) 14·8 6·4 16·2 6·6 17·3 6·7 ,0·001
Fibre (g/d) 25·0 8·7 25·6 8·7 25·3 7·8 0·066
Total cholesterol (mg/d) 346 119 382 123 385 113 ,0·001
Food groups (g/d)
Fruits 370 204 372 205 352 199 ,0·001
Vegetables 332 149 342 152 328 138 0·023
Cereals 137 81 145 83 169 97 ,0·001
Meat 125 55 136 55 146 58 ,0·001
Fish 96 46 105 58 105 47 ,0·001
Legumes 21 14 21 13 20 10 0·162
Dairy products 403 227 374 218 309 197 ,0·001
Olive oil 38 18 40 18 42 16 ,0·001
Nuts 9 12 11 15 12 14 ,0·001
Soft drinks 15 58 20 57 18 61 0·025
13-point MedDiet questionnaire score† 8·34 1·86 8·35 1·90 8·26 1·84 0·56
MedDiet, Mediterranean diet.
* One-way ANOVA tests.
† The 14-point questionnaire of adherence to the traditional MedDiet excluding the question regarding wine intake.
Table 3. Pearson’s correlation coefficients between the intake of
different alcoholic beverage groups and that of red wine (drinks/d)
Entire sample
(n 5801)
Men
(n 2433)
Women
(n 3368)
r P r P r P
White,
rose´ and
sparkling
wines
0·02 0·23 20·05 0·018 0·02 0·35
Beer 0·17 ,0·001 0·09 ,0·001 0·10 ,0·001
Liquors 0·12 ,0·001 0·08 ,0·001 0·10 ,0·001
Spirits 0·14 ,0·001 0·08 ,0·001 0·09 ,0·001
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heavy drinkers (.2 drinks/d for women and .4 drinks/d for
men) in sensitivity analyses (data not shown). With regard to
individual components of the MetS, participants who were
in the highest RW intake category had a 41 % lower risk of
having an abnormal waist circumference (OR 0·59, 95 % CI
0·46, 0·77; P,0·001), a 58 % lower risk of having low HDL-c
concentrations (OR 0·42, 95 % CI 0·32, 0·53; P,0·001), a
72 % lower risk of having high BP (OR 0·28, 95 % CI 0·17,
0·45; P,0·001) and a 33 % lower risk of having high fasting
plasma glucose concentrations (OR 0·67, 95 % CI 0·54, 0·82;
P,0·001) compared with non-consumers. A protective effect
of RW intake on TAG concentrations that lost significance
after adjustment for all potential confounders was also
observed.
Analysis performed after stratifying the sample by sex
revealed a lower risk of the MetS in women consuming .1
drink/d (OR 0·47, 95 % CI 0·30, 0·73; P trend ,0·001) than
in men (OR 0·68, 95 % CI 0·53, 0·88; P trend 0·004) after
multivariate adjustment (Table 6). Analysis performed after
stratifying the sample by age groups (,70 years and $70
years) revealed that the effects of RW intake to be significant
only for the youngest group (OR 0·49, 95 % CI 0·38, 0·63;
P trend ,0·001). When analysing the association between
the prevalence of the MetS and RW intake among participants
stratified by smoking status, a 43 % reduction in the risk of the
MetS in former or current smokers (OR 0·57, 95 % CI 0·43, 0·75;
P trend ,0·001) and a 40 % reduction among those who never
smoked were observed. For all stratum categories, a trend
towards a lower risk of the MetS was observed in both the
crude and adjusted models, although not all models achieved
statistical significance.
The association between the prevalence of the MetS and the
intake of different types of alcoholic beverages was also ana-
lysed. After adjusting for all confounders, beer intake was
found to be associated with an increased risk of the MetS
(OR 1·50, 95 % CI 1·08, 2·10; P trend 0·005) due to its asso-
ciation with abdominal obesity (OR 1·49, 95 % CI 1·01, 2·19;
P trend 0·049). However, when the association between
beer intake and waist:height ratio (anthropometric index of
abdominal fat distribution) was analysed, the association
was found to lose the statistical significance (OR 0·67; 95 %
CI 0·23, 1·97; P trend 0·970). None of the other metabolic
criteria varied significantly with beer intake. Analysis of the
intake of other alcoholic beverages in relation to the pre-
valence of the MetS revealed no significant associations for
the intake of white, rose´ and sparkling wines or for that
of liquors and spirits, although the intake of these types of
alcoholic beverages was scarce in the study population.
Discussion
In the present cross-sectional study of 5801 elderly partici-
pants at a high cardiovascular risk included in the PREDIMED
study, 3897 MetS cases were found, representing a prevalence
of 67·2 %, which was not unexpected given that only indivi-
duals with diabetes or three or more standard cardiovascular
risk factors, including overweight or obesity, were eligible
for inclusion in the study. In this setting, moderate RW
Table 4. Metabolic risk parameters of 5801 participants from the PREDIMED (Prevencio´n con Dieta Mediterra´nea) cohort according to categories of
red wine intake at baseline (energy-adjusted)
(Mean values and standard deviations; number of participants and percentages)
Non-drinkers (n 3037) 0·1–1 drink/d (n 2086) .1 drink/d (n 678)
Mean SD Mean SD Mean SD P *
BMI (kg/m2) 30·7 4·1 29·7 3·6 29·2 3·3 ,0·001
Waist:height ratio 0·64 0·07 0·62 0·06 0·61 0·06 ,0·001
Systolic BP (mmHg) 150·4 19·5 148·6 19·2 152·7 19·6 ,0·001
Diastolic BP (mmHg) 82·7 10·3 83·1 10·2 84·7 10·6 ,0·001
Hearth rate (beats/min) 72·3 11·1 69·8 10·1 69·1 10·9 ,0·001
Glucose (mg/dl) 123·1 41·3 118·7 39·0 117·1 33·7 ,0·001
Lipid profile (mg/dl)
Total cholesterol 206·3 37·6 205·3 37·6 206·8 37·8 0·579
HDL-c 52·8 12·1 52·1 12·4 52·8 12·0 0·099
LDL-c 128·5 33·7 130·8 36·8 131·3 33·5 0·032
TAG 137·3 77·5 127·8 73·6 131·8 73·7 ,0·001
Metabolic syndrome and components n
Percentage
of the total n
Percentage
of the total n
Percentage
of the total P†
Metabolic syndrome 2268 74·7 1267 60·7 362 53·4 ,0·001
Abnormal waist circumference 2560 84·3 1437 68·9 390 57·5 ,0·001
High TAG concentrations or
lipid-lowering treatment
1042 34·3 612 29·3 220 32·4 ,0·001
Low HDL-c concentrations 999 32·9 585 28·0 99 14·6 ,0·001
High BP or antihypertensive treatment 2990 98·5 1932 92·6 639 94·2 ,0·001
High fasting plasma glucose
concentrations or antidiabetic treatment
2125 70·0 1309 62·7 442 65·2 ,0·001
BP, blood pressure; HDL-c, HDL-cholesterol; LDL-c, LDL-cholesterol.
* One-way ANOVA tests.
† x 2 tests.
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consumption was found to be associated with a decreased
prevalence of the MetS, mainly by reducing the risk of
having an abnormal waist circumference, high BP, low
HDL-c concentrations and high fasting plasma glucose con-
centrations. This association was stronger in participants
aged ,70 years, in participants who were former or current
smokers, and also in female participants. In fact, women
consuming .1 drink/d had a lower risk of the MetS than
men. Several studies have demonstrated that women are
more sensitive to the toxic effects of alcohol than men(23).
Therefore, the recommended upper limit of alcohol consump-
tion for women is half of that recommended for men(24). On
the other hand, several studies have also reported the bene-
ficial effects of moderate alcohol consumption in women
even when consuming less amounts of alcohol when com-
pared with men(25). The results of the present study confirm
the greater beneficial effects of moderate RW consumption
on the incidence of the MetS in women than in men.
The intake of RW was weakly but positively associated with
that of beer, liquors and spirits, but was not associated with
the intake of other types of wines. This suggests that RW con-
sumers are more likely to consume beer, liquors and spirits
than white wine, rose´ wine or sparkling wine. However,
although significant, correlation coefficients were too low to
draw conclusions. On the other hand, no association was
found between the incidence of the MetS and the consump-
tion of alcoholic beverages other than RW.
Wine is considered to be a key component of the traditional
MedDiet. Several previous cohort and intervention studies
have examined the effects of observed Mediterranean-type
diets on the risk of the MetS and its components. The pros-
pective Framingham Heart Study Offspring Cohort study was
the first to report a protective effect of the MedDiet on the
MetS, as participants in the highest quintile of MedDiet
adherence had a 30·1 % incidence rate of the MetS compared
with those in the lowest quintile category (38·5 %; P¼0·01)(26).
Other, albeit not all(27), cross-sectional studies carried out in
Mediterranean countries(2,28–31) have reported an inverse
association between quartiles of adherence to the MedDiet
and the incidence of the MetS. A recent meta-analysis of fifty
studies has confirmed that the higher the adherence to the
MedDiet, the lower the prevalence and progression of the
MetS(32). Interestingly, intervention studies including MetS
patients have confirmed that the MedDiet may favour the
regression of the MetS and prevent its progression(33,34).
However, few studies have analysed the role of moderate
RW consumption in the prevalence of the MetS. Similar to
the present study, a study carried out in the Canary Islands
(Spain) showed the intake of wine, as well as that of other
components of the traditional MedDiet such as fruits,
Table 5. Risk of the metabolic syndrome and individual metabolic syndrome components according to red wine intake categories (0·1–1 drink/d and
.1 drink/d groups compared with the non-drinker group)
(Odds ratios* and 95 % confidence intervals)
0·1–1 drink/d P† .1 drink/d P†
Metabolic syndrome‡
Unadjusted OR 0·53 ,0·001 0·39 ,0·001
95 % CI 0·47, 0·90 0·33, 0·46
Multivariable OR§ 0·64 ,0·001 0·56 ,0·001
95 % CI 0·56, 0·73 0·45, 0·68
Abnormal waist circumference (.102 cm in men and .88 cm in women or treatment)
Unadjusted OR 0·40 ,0·001 0·24 ,0·001
95 % CI 0·35, 0·45 0·20, 0·29
Multivariable OR§ 0·64 ,0·001 0·59 ,0·001
95 % CI 0·53, 0·78 0·46, 0·77
TAG ($150 mg/dl or TAG-lowering medication)
Unadjusted OR 0·76 ,0·001 0·89 0·18
95 % CI 0·68, 0·86 0·74, 1·06
Multivariable OR§ 0·76 ,0·001 0·87 0·18
95 % CI 0·66, 0·86 0·71, 1·06
HDL-cholesterol (,40 mg/dl in men and ,50 mg/dl in women or lipid-lowering treatment)
Unadjusted OR 0·76 ,0·001 0·34 ,0·001
95 % CI 0·68, 0·87 0·27, 0·42
Multivariable OR§ 0·85 0·015 0·42 ,0·001
95 % CI 0·75, 0·97 0·32, 0·53
Blood pressure ($130/85 mmHg or antihypertensive treatment)
Unadjusted OR 0·20 ,0·001 0·26 ,0·001
95 % CI 0·14, 0·28 0·17, 0·40
Multivariable OR§ 0·22 ,0·001 0·28 ,0·001
95 % CI 0·16, 0·31 0·17, 0·45
Fasting plasma glucose ($100 mg/dl or antidiabetic treatment)
Unadjusted OR 0·70 ,0·001 0·79 0·01
95 % CI 0·62, 0·79 0·66, 0·95
Multivariable OR§ 0·65 ,0·001 0·67 ,0·001
95 % CI 0·57, 0·74 0·54, 0·82
* OR were calculated using logistic regression analysis.
† Two-sided test of significance.
‡ The metabolic syndrome was considered to occur when at least three of the five metabolic criteria were fulfilled.
§ Adjusted for sex, age, BMI, smoking status, educational level, physical activity, total energy intake and diet.
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vegetables and cereals, to be inversely associated with the
prevalence of the MetS(23). Indeed, it has been suggested
that not all components of the MedDiet are likely to provide
the same level of protection(35).
Several studies with different designs have suggested that
the greater health benefits of moderate consumption of
RW might be related to its higher polyphenolic content com-
pared with other alcoholic beverages. In fact, polyphenols
may provide additional benefits to consumers of other alco-
holic beverages by decreasing BP, inhibiting LDL oxidation,
improving endothelial function and reducing inflammation
and cell adhesion molecule levels(36). In the present study,
an association between regular RW consumption and hyper-
tension was found, contrary to that reported in other
studies(37). In a recent feeding trial, systolic and diastolic BP
were found to be significantly decreased after 4 weeks of
intervention with dealcoholised RW, but not after RW or gin
interventions(8).
The best-established protective factor of alcohol intake is
the increase in plasma HDL-c concentrations(38,39). A meta-
analysis of clinical studies assessing the effects of moderate
alcohol consumption on HDL-c concentrations has indicated
that the intake of 30 g/d of ethanol increases HDL-c concen-
trations by a mean of 4·0 mg/dl and TAG concentrations by
5·7 mg/dl, irrespective of the alcoholic beverage consumed.
It has been estimated that an average intake of 30 g of
ethanol/d would cause an estimated reduction of 24·7 % in
the risk of CHD(40). In addition, both cross-sectional and
intervention studies have shown that moderate RW consump-
tion reduces the plasma concentrations of in vivo oxidised
LDL(41,42), which has been reported to be associated with
the polyphenolic content of RW.
Moderate alcohol consumption has also been reported to
be inversely associated with the risk of diabetes in a meta-
analysis of observational studies that included data from
477 200 men and women participating in prospective cohort
Table 6. Stratified analyses of the risk of the metabolic syndrome according to red wine intake categories*
(Odds ratios† and 95 % confidence intervals)
Non-drinkers 0·1–1 drink/d .1 drink/d P for trend P interaction
Sex
Males
No. of cases/total 482/738 670/1113 313/582
Unadjusted OR Ref 0·80 0·61 ,0·001 0·41
95 % CI 0·66, 0·97 0·49, 0·78
Multivariable OR‡ Ref 0·91 0·68 0·004 0·02
95 % CI 0·73, 1·13 0·53, 0·88
Females
No. of cases/total 1786/2299 597/973 49/96
Unadjusted OR Ref 0·46 0·30 ,0·001
95 % CI 0·39, 0·54 0·20, 0·45
Multivariable OR‡ Ref 0·52 0·47 ,0·001
95 % CI 0·44, 0·62 0·30, 0·73
Age (years)
, 70
No. of cases/total 1354/1801 851/1414 249/480
Unadjusted OR Ref 0·50 0·36 ,0·001 0·18
95 % CI 0·43, 0·58 0·29, 0·44
Multivariable OR‡ Ref 0·61 0·49 ,0·001 0·19
95 % CI 0·51, 0·72 0·38, 0·63
$ 70
No. of cases/total 914/1236 416/672 113/198
Unadjusted OR Ref 0·57 0·47 ,0·001
95 % CI 0·47, 0·70 0·34, 0·64
Multivariable OR‡ Ref 0·70 0·72 0·005
95 % CI 0·56, 0·88 0·50, 1·03
Smoking status
Never
No. of cases/total 1746/2297 675/1117 101/193
Unadjusted OR Ref 0·48 0·35 ,0·001 0·27
95 % CI 0·41, 0·56 0·26, 0·47
Multivariable OR‡ Ref 0·60 0·60 ,0·001 0·004
95 % CI 0·51, 0·71 0·43, 0·85
Ever
No. of cases/total 522/740 592/969 261/485
Unadjusted OR Ref 0·66 0·48 ,0·001
95 % CI 0·54, 0·81 0·38, 0·61
Multivariable OR‡ Ref 0·76 0·57 ,0·001
95 % CI 0·60, 0·95 0·43, 0·75
Ref, reference.
* The metabolic syndrome was considered to occur when at least three of the five metabolic criteria were fulfilled.
† OR were calculated using logistic regression analysis.
‡ Adjusted for sex, age, BMI, smoking status, educational level, physical activity, total energy intake and diet.
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studies. The dose–response trend showed that the alcohol
intake of 22–24 g/d had the strongest inverse association,
but alcohol intake became deleterious over 60 g/d in men
and over 50 g/d in women(43,44).
In addition, randomised clinical trials have also demon-
strated that moderate alcohol intake (30 g/d) has bene-
ficial effects on insulin and TAG concentrations and insulin
sensitivity in non-diabetic postmenopausal women(45), sugg-
esting that moderate alcohol consumption decreases the risk
of CVD and type 2 diabetes by improving insulin sensitivity.
Similar to that observed in other studies(46,47), RW drinkers
had significantly reduced BMI and waist circumference
when compared with non-drinkers in the present study.
Thus, moderate alcohol consumption, as observed in the
Tromso Study(47), as well as moderate RW consumption, as
observed in the Danish Diet Cancer and Health Study(46),
exerts a beneficial effect by lowering the risk of abdominal
obesity in women. Dietary factors including animal fat and
refined carbohydrates are postulated to induce oxidative
stress that stimulates inflammation in obesity. By contrast,
some foods including wine, fruits, vegetables, nuts and
others exert antioxidant and anti-inflammatory effects that
may prevent the development of the MetS(48,49).
The present study has a few limitations. First, as the
study participants were elderly Spanish people at a high risk
of CVD, findings from the study cannot be extrapolated
to younger lower-risk populations from other countries.
Furthermore, studying high-cardiovascular risk individuals
is a limitation rather than an advantage for testing our
hypothesis. Another limitation is the cross-sectional nature of
the study, which does not allow inferring causal relationships
between the MedDiet and the MetS. The present study also
has strengths, such as the large sample size and the high
number of participants with the MetS, the use of a validated
FFQ and the ability to control for potential confounders due
to recording of comprehensive data on risk factors, diet and
sociodemographic variables. On the other hand, the study
population is not representative of the general Spanish popu-
lation. Although many potential confounders were controlled
for in multivariate models, other unknown or unmeasured
confounders may exist.
Conclusions
Compared with non-drinkers, moderate RW drinkers from
an elderly population at a high cardiovascular risk have a
lower risk of developing the MetS and having abnormal
waist circumference, low HDL-c concentrations, high BP and
hyperglycaemia, four of the five individual metabolic criteria
included in its definition.
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